chugai pharmaceutical co ltd
(4519:Tokyo Stock Exchange)
Chairman and Chief Executive Officer,Chugai Pharmaceutical Co. Ltd.
|Age||Total Calculated Compensation||This person is connected to 49 board members in 4 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Mr. Osamu Nagayama has been the Chairman and Chief Executive Officer of Chugai Pharmaceutical Co. Ltd. since March 28, 2012. Mr. Nagayama served as President and Chief Operating Officer of Chugai Pharmaceutical Co. Ltd. until February 2012. He has been with Chugai Pharmaceutical Co. Ltd. since 1978. He served as a Director of Pharmaceutical Sales & Marketing Division and International Business Division of Chugai since 1983, Deputy General Manager of Pharmaceutical Research ...
Nihonbashi Mitsui TowerPhone: 81 3 3281 6611
Tokyo, -- 103-8324
Fax: 81 3 3281 6607
Board Members Memberships*
Director and Chairman of the Board of Directors of Sony Corporation
Chairman and Chief Executive Officer
Chairman of The Board and Chairman of Nominating Committee
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|Robert A. Bradway||Chairman, Chief Executive Officer, Chairman of Executive Committee and Member of Equity Award Committee|
|Giovanni Caforio M.D.||Chief Executive Officer and Director|
Bristol-Myers Squibb Company
|Omar S. Ishrak||Chairman and Chief Executive Officer|
|Ian C. Read||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Joseph Jimenez Jr., MBA||Chief Executive Officer|
|SFr.5.2M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.